Contact
searchSearch
HMP Global

From the Editor

Letter from the Editor
Does the Presence of an Isoelectric Period Predict the Mechanism of a Post-Ablation Atrial Arrhythmia?
11/01/2024
A study using ultra-high-density mapping of post-ablation atrial arrhythmias teaches us that over one-third of patients who present with an atrial tachycardia that demonstrates an isoelectric period actually have a macroreentrant mechanism.
A study using ultra-high-density mapping of post-ablation atrial arrhythmias teaches us that over one-third of patients who present with an atrial tachycardia that demonstrates an isoelectric period actually have a macroreentrant mechanism.
A study using ultra-high-density...
11/01/2024
EP Lab Digest
Letter from the Editor
How Was a Sham-Controlled Trial for Atrial Fibrillation Ablation in Humans Ever Justified?
09/04/2024
In September 2024, the first sham-controlled AF ablation trial was published simultaneous with presentation of the study findings at the European Society of Cardiology (ESC) Congress 2024.
In September 2024, the first sham-controlled AF ablation trial was published simultaneous with presentation of the study findings at the European Society of Cardiology (ESC) Congress 2024.
In September 2024, the first...
09/04/2024
EP Lab Digest
Letter from the Editor
Hospital Rankings for Heart and Heart Surgery Need to Include Electrophysiology Procedures in Their Metrics
09/01/2024
Historically, more resources, attention, and personnel are dedicated to the cardiac operating rooms, cardiac intensive care units, and catheterization laboratories than to the EP laboratories. There are many reasons why.
Historically, more resources, attention, and personnel are dedicated to the cardiac operating rooms, cardiac intensive care units, and catheterization laboratories than to the EP laboratories. There are many reasons why.
Historically, more resources,...
09/01/2024
EP Lab Digest
Letter from the Editor
Reducing the Rate of Serious Adverse Events in the Cardiac Electrophysiology Laboratory From 2% to 1%
08/16/2024
It is unrealistic to expect zero complications from an invasive procedure. It is also important to learn that trying to lower the rate of serious adverse events from 2% to 1% in the EP lab can require much more than twice the effort.
It is unrealistic to expect zero complications from an invasive procedure. It is also important to learn that trying to lower the rate of serious adverse events from 2% to 1% in the EP lab can require much more than twice the effort.
It is unrealistic to expect zero...
08/16/2024
EP Lab Digest
Letter from the Editor
Are Disease-Modifying Treatments on the Horizon for Patients With Arrhythmogenic Right Ventricular Cardiomyopathy?
07/02/2024
Gene therapy targeting the underlying desmosomal mutation and approaches to prevent myocardial fibrosis independent of the specific genetic defect by increasing cardiac levels of FGF21 may be on the horizon for patients with ARVC.
Gene therapy targeting the underlying desmosomal mutation and approaches to prevent myocardial fibrosis independent of the specific genetic defect by increasing cardiac levels of FGF21 may be on the horizon for patients with ARVC.
Gene therapy targeting the...
07/02/2024
EP Lab Digest
Letter from the Editor
Question: Which Antiarrhythmic Drugs Carry a Class I Recommendation for Rhythm Control in the 2023 AHA/ACC/ACCP/HRS Atrial Fibrillation Guideline? Answer: None.
05/29/2024
It is surprising that in the latest atrial fibrillation guideline, not a single antiarrhythmic drug is considered to have a class I indication.
It is surprising that in the latest atrial fibrillation guideline, not a single antiarrhythmic drug is considered to have a class I indication.
It is surprising that in the...
05/29/2024
EP Lab Digest
Letter from the Editor
Complete Spontaneous Resolution of Very Frequent Premature Ventricular Contractions
05/17/2024
The indications for catheter ablation of idiopathic PVCs should remain limited to patients with significant symptoms or baseline left ventricular dysfunction.
The indications for catheter ablation of idiopathic PVCs should remain limited to patients with significant symptoms or baseline left ventricular dysfunction.
The indications for catheter...
05/17/2024
EP Lab Digest
Letter from the Editor
The Key Reason Why Pulsed Field Ablation Will be Embraced: Fear of an Atrio-Esophageal Fistula After Thermal Ablation
04/14/2024
Avoiding an atrio-esophageal fistula remains a concern during atrial fibrillation ablation procedures.
Avoiding an atrio-esophageal fistula remains a concern during atrial fibrillation ablation procedures.
Avoiding an atrio-esophageal...
04/14/2024
EP Lab Digest
Letter from the Editor
Smartwatch-Guided “Pill-in-a-Pocket” Anticoagulation for Atrial Fibrillation: The REACT-AF Trial
03/07/2024
The advent of numerous wearable devices, including AF-sensing smartwatches that are capable of detecting AF, has opened the possibility that direct oral anticoagulation could be prescribed for only a few days after an episode of AF.
The advent of numerous wearable devices, including AF-sensing smartwatches that are capable of detecting AF, has opened the possibility that direct oral anticoagulation could be prescribed for only a few days after an episode of AF.
The advent of numerous wearable...
03/07/2024
EP Lab Digest
Letter From the Editor
False-Positive Patient Activations and Why Reviewing the Results of Ambulatory Monitoring With Patients is Critical
02/12/2024
Despite improvements in ambulatory monitoring, it is still critical that findings be reviewed directly with the patient to accurately interpret the results and to correlate any symptoms with their rhythm at the time.
Despite improvements in ambulatory monitoring, it is still critical that findings be reviewed directly with the patient to accurately interpret the results and to correlate any symptoms with their rhythm at the time.
Despite improvements in...
02/12/2024
EP Lab Digest
EPLD November 2024 cover

Current Issue

November 2024
Volume 24
Issue 11
Current Issue
Issue Archive

Stay in the know.

EP Lab Digest Newsletter

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use